NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Jan 6, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Stock Option (right to buy)
2016-01-04+16,032→ 23,246 totalExercise: $2.02From: 2016-01-04Exp: 2026-01-04→ Common Stock (16,032 underlying)
Footnotes (3)
- [F1]Granted pursuant to the 2007 Omnibus Incentive Plan and the 2016 Non-Employee Director Compensation Plan
- [F2]Stock options will vest in equal monthly installments over one year starting from the date of grant
- [F3]On December 18, 2015, the common stock of NovaBay Pharmaceuticals reverse split 1-for-25, and is reflected accordingly in both the number of underlying option shares and exercise price of the award.